Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)

被引：0
|
作者：
Thitima Kongnakorn
Christian Eckmann
Matteo Bassetti
Eszter Tichy
Roberto Di Virgilio
Nathalie Baillon-Plot
Claudie Charbonneau
机构：
[1] Evidera,Klinikum Peine
[2] The Ark,Infectious Diseases Clinic, Department of Health Sciences
[3] Academic Hospital of Medical University Hannover,undefined
[4] University of Genoa,undefined
[5] Genoa and Hospital Policlinico San Martino IRCCS,undefined
[6] Evidera,undefined
[7] Pfizer,undefined
[8] Pfizer,undefined
来源：
Antimicrobial Resistance & Infection Control | / 8卷
关键词：
Economic model; Cost-effectiveness analysis; Ceftazidime-avibactam plus metronidazole; Ceftolozane/tazobactam plus metronidazole; Meropenem; Complicated intra-abdominal infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 41 条
  • [1] Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)
    Kongnakorn, Thitima
    Eckmann, Christian
    Bassetti, Matteo
    Tichy, Eszter
    Di Virgilio, Roberto
    Baillon-Plot, Nathalie
    Charbonneau, Claudie
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2019, 8 (01)
  • [2] Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
    Goodlet, Kellie J.
    Nicolau, David P.
    Nailor, Michael D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1811 - 1826
  • [3] COST-EFFECTIVENESS OF CEFTAZIDIME/AVIBACTAM VERSUS MEROPENEM IN THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN CHINA
    Hu, Q.
    Tao, X.
    Jiang, M.
    Long, E.
    VALUE IN HEALTH, 2022, 25 (07) : S380 - S380
  • [4] BUDGET IMPACT OF CEFTAZIDIME AVIBACTAM (CAZ-AVI) FOR COMPLICATED INTRA-ABDOMINAL INFECTION, COMPLICATED URINARY TRACT INFECTION AND HOSPITAL-ACQUIRED PNEUMONIA IN SINGAPORE
    Park, D. J.
    New, J. W.
    VALUE IN HEALTH, 2019, 22 : S652 - S652
  • [5] Ceftazidime-Avibactam versus Meropenem for the Treatment of Complicated Intra-Abdominal Infections
    Tan, Che-Kim
    Lai, Chih-Cheng
    Chao, Chien-Ming
    ANTIBIOTICS-BASEL, 2019, 8 (04):
  • [6] BUDGET IMPACT OF INTRODUCING CEFTAZIDIME-AVIBACTAM (CAZ-AVI) FOR COMPLICATED INTRA-ABDOMINAL INFECTION (CIAI), COMPLICATED URINARY TRACT INFECTIONS (CUTI), AND HOSPITAL ACQUIRED PNEUMONIA INCLUDING VENTILATOR-ASSOCIATED PNEUMONIA (HAPNAP) TO A HOSPITAL FORMULARY IN ITALY
    KongnakornT
    Tichy, E.
    Merinopoulou, E.
    Berto, M.
    Di Virgilio, R.
    Charbonneau, C.
    VALUE IN HEALTH, 2017, 20 (09) : A782 - A782
  • [7] COST-EFFECTIVENESS OF CEFTOLOZANE/TAZOBACTAM PLUS METRONIDAZOLE AS EMPIRIC THERAPY FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN COLOMBIA
    Lasalvia, P.
    Rosselli, D.
    Castaneda-Cardona, C.
    Garzon, J.
    Hernandez, F.
    Beltran, C.
    Rojas, M.
    Lopez, M. C.
    Sarpong, E. M.
    VALUE IN HEALTH, 2018, 21 : S152 - S153
  • [8] COST-EFFECTIVENESS ANALYSIS OF TIGECICLINE IN THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTION IN MEXICO
    Tellez-Giron, G.
    Soto-Molina, H.
    Rizzoli-Cordova, A.
    Diaz-Ponce, H.
    Galindo-Suarez, R. M.
    VALUE IN HEALTH, 2012, 15 (04) : A242 - A243
  • [9] Ceftazidime-avibactam (CTZ-AVI) as a treatment for hospitalized adult patients with complicated intra-abdominal infections
    Gardiner, Bradley J.
    Golan, Yoav
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (05) : 451 - 463
  • [10] COST-EFFECTIVENESS OF CEFTAZIDIME-AVIBACTAM plus METRONIDAZOLE AS A FIRST-LINE TREATMENT IN PATIENTS WITH COMPLICATED INTRA-ABDOMINAL INFECTIONS IN TAIWAN
    Chen, Y. C.
    Wen, Y. C.
    Wang, B.
    Furnback, W.
    Charbonneau, C.
    Lin, S. W.
    Huang, S. T.
    Chen, H. M.
    Hsiao, F. Y. S.
    VALUE IN HEALTH, 2019, 22 : S642 - S643
12345